Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of CF as defined by two or more clinical features of CF and a documented sweat chloride \> 60 mEq/L by quantitative pilocarpine iontophoresis test or a genotype showing two well characterized disease causing mutations~* Informed consent and verbal assent (as appropriate) provided by the subject's parent or legal guardian and the subject~* 6-18 years of age at enrolment and able to perform reproducible spirometry~* Clinically stable at enrolment~* FEV1 % predicted ≥ 80 % as calculated by the Wang reference equations~* Ability to comply with medication use, study visits and study procedures~Exclusion Criteria:~* Respiratory culture positive for NTM or B. cepacia complex within past year or screening~* Use of intravenous antibiotics or oral quinolones within 14 days of screening~* Investigational drug use within 30 days of screening~* Physical findings at screening that would compromise the safety of the participant or the quality of the study data

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).